Interactive Workshop 2 - Deprescribing and addressing polypharmacy: a delicate balance between reducing medication burden and improving patient outcomes?

45 min interactive workshop sessions, with four running concurrently

2) Deprescribing and polypharmacy: How should progress be measured? - in partnership with Optum

Is 'addressing problematic polypharmacy' one of your top 16 national medicines optimisation opportunities this year? Have you identified the right tools and measures to define and document the impact you can make?

Learning from others’ experiences so far, this interactive discussion aims to examine how you are measuring progress in the short, medium and long term with a focus on:

• Structured medication reviews
• Use of appropriate clinical coding, tools and technology
• Deprescribing and non-adherence within specific patient cohorts
• The role of community pharmacy in closing the loop on missing data points